Seattle Genetics Profile

USD 0.07  0.1%

Seattle Genetics exotic insider transaction detected

Seattle Genetics insider trading alert for general transaction of warrants by Srinivas Akkaraju, the corporate stakeholder, on July 14, 2018. This event was filed by Seattle Genetics Inc with SEC on 2008-05-19. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Seattle Genetics Summary

Seattle Genetics (SGEN) is traded on NASDAQ in USA. It is located in 21823 30th Drive SE and employs 1,100 people. The company currently falls under 'Large-Cap' category with current market capitalization of 11.15 B. Seattle Genetics conducts business under Healthcare sector and is part of Biotechnology industry. This company has 158.22 M outstanding shares of which 14.62 M shares are at this time shorted by private and institutional investors with about 15.81 trading days to cover. SEATTLE GENETICS currently holds about 399.92 M in cash with (202.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.53.
Check Seattle Genetics Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 70.45HorizonTargetOdds Above 70.45
95.77%30 days 70.45 4.13%
Based on normal probability distribution, the odds of Seattle Genetics to move above current price in 30 days from now is nearly 4.13% (This Seattle Genetics probability density function shows the probability of Seattle Genetics Stock to fall within a particular range of prices over 30 days) .

Top Holders

Selected Seattle Genetics Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Seattle Genetics Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Seattle Genetics are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Seattle Genetics, Inc., a biotechnology company, focuses on the development and commercialization of targeted therapies for the treatment of cancer worldwide. Seattle Genetics, Inc. was founded in 1998 and is headquartered in Bothell, Washington. Seattle Genetics operates under Biotechnology classification in USA and traded on NASDAQ. It employs 1100 people. more
NameSeattle Genetics
ChairmanClay SiegallView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
Business Address21823 30th Drive SE
CIK Number0001060736
Phone425 527 4000
CurrencyUSD - US Dollar

Current Sentiment - SGEN

Seattle Genetics Investor Sentiment
Most of Macroaxis users are at this time bullish on Seattle Genetics. What is your outlook on investing in Seattle Genetics? Are you bullish or bearish?
98% Bullish
2% Bearish

Seattle Genetics Corporate Directors

Pinkston Peggy Senior Director - Corporate Communications
David Gryska Independent Director, MBA
Daniel Welch Independent Director, MBA
Also please take a look at World Market Map. Please also try Portfolio Manager module to state of the art portfolio manager to monitor and improve performance of your invested capital.